QVAR® real-world study to be presented at annual ATS International Conference

(Tonic Life Communications USA) Teva Pharmaceutical Industries Ltd., today announced that results from a real-life, retrospective, observational study of QVAR® will be presented at the American Thoracic Society 2014 International Conference in San Diego on May 18, 2014. QVAR® is an inhaled corticosteroid indicated in the maintenance treatment of asthma as a prophylactic therapy in patients 5 years of age and older.